NovaBridge Biosciences (Nasdaq: NBP), an SEC filer in Pharmaceutical Preparations, closed at $1.89, +1.1%, on 2026-08-27, with a return on equity of -21.4%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles
Shares short
4.6M
% of shares out
1.7%
Days to cover
20.3
Δ vs 2026-07-31
+1.3%
bars = shares short · line = days to cover (own scale)
Settlement
Shares short
Δ vs prior
Avg daily volume
Days to cover
2026-08-14
4,575,902
+1.3%
225,162
20.3
2026-07-31
4,519,614
+4.4%
259,475
17.4
2026-07-15
4,327,479
+24.7%
712,132
6.1
2026-06-30
3,469,413
-16.6%
846,887
4.1
2026-06-15
4,161,491
+16.1%
491,271
8.5
2026-05-29
3,584,689
-27.5%
800,719
4.5
FINRA Rule 4560 · twice monthly, published ~a week later.
